U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07362017) titled 'Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis' on Jan. 20.
Brief Summary: An open label study to investigate the safety and efficacy of ponesimod in participants with moderate-to-severe chronic plaque psoriasis
Study Start Date: Jan., 2026
Study Type: INTERVENTIONAL
Condition:
Moderate-to-severe Chronic Plaque Psoriasis
Intervention:
DRUG: Ponesimod
Oral Tablet
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Vanda Pharmaceuticals
Published by HT Digital Content Services with permission from Health Daily Digest....